This website uses cookies to improve functionality and performance. With a click on the OK button you are giving implied consent to the use of cookies on this website.
More information
EnglishDeutsch
de
EnglishDeutsch
de
Login Environment Pharma

SYNLAB pharma is your specialist partner for biomarker discovery and development

During the non-clinical phase, we can assist in identifying the biomarkers that prove the efficacy of your drug compound.

We offer a broad range of established biomarkers ready to be included in the testing panels of your study protocols.

SYNLAB pharma has a range of multiplex systems available for the investigation of biomarker suitability; these systems are capable of simultaneously measuring up to 50 biomarkers in a single 50uL sample – a most cost-efficient solution

Contact us



News & Events

View All
Fellbach wird neuer Laborstandort
Nach zweijähriger Planungs- und Umbauphase entstand in Fellbach das neue Labor der SYNLAB Analytics & Services Germany GmbH.
Aug 10, 2018 Continue
Determination of the Impurity N-Nitroso dimethyl amine (NDMA) in Drug Substances with GC-MS

Due to contamination of a drug substance with the potential mutagenic substance N-Nitroso dimethyl amine (NDMA) a massive recall campaign was initiated for the related drug products. SYNLAB Pharma offers a GC-MS test for testing the absence of NDMA in drug substances and drug products.

Please contact our experts.

Jul 13, 2018 | Pharma Continue
New Services in Regulatory Compliance for Biologics

With immediate effect, SYNLAB Pharma provides a broad support in the field of Regulatory Compliance of Biologics development. With this new services we support specifically start-ups, small to medium sized biotech companies, which require professional consultancy and project execution in regulatory project design.

For further questions, please contact:

pharma@synlab.com

Jun 18, 2018 | Pharma Continue
View All